Skip to main content
. 2017 Oct 18;8:1305. doi: 10.3389/fimmu.2017.01305

Table 5.

Comparison of post- (T2) therapeutic heat shock protein 70 (Hsp70) plasma levels in non-responding and responding non-small-cell lung cancer patients (M0).

Therapy response (T2) Median Hsp70 above 5 ng/ml Median Hsp70 below 5 ng/ml
N 14 12
Non-responder 1 (7%) 6 (50%)
Responder 13 (93%) 6 (50%)
Pearson chi-square p = 0.02

Patients were divided into two subgroups with high and low median Hsp70 levels.